Published March 29, 2026 | Version v1

Biomedical Sciences of Adiantum species

  • 1. Postgraduate Department of Botany and Research Centre, R. B. Narayanrao Borawake College, (Autonomous) Shrirampur-413709
  • 2. PG Department of Botany, Adv. M. N. Deshmukh College, Rajur, 422604

Description

Adiantum species, commonly known as maidenhair ferns, belong to the Pteridaceae family and have been utilized in traditional medicine across various cultures for treating respiratory ailments, skin disorders, inflammation, and other conditions. This chapter reviews the biomedical sciences of key Adiantum species, focusing on their phytochemistry and validated pharmacological activities, including antimicrobial, antioxidant, anti-inflammatory, anticancer, and antidiabetic effects, as reported in recent studies up to 2025. Over 130 bioactive compounds, including flavonoids (rutin, quercetin, luteolin), phenolic acids (chlorogenic acid, and caffeic acid), and terpenoids, underpin these properties, with promising in vitro, in vivo, and in silico evidence. Despite low toxicity profiles, clinical trials remain scarce, highlighting the need for standardized extracts, mechanistic studies, and therapeutic formulations. Recent advancements in extraction techniques, like supercritical fluid extraction, enhance compound isolation for biomedical applications.

Files

36. Somnath S. Shinde.pdf

Files (331.9 kB)

Name Size Download all
md5:ec17f67f54eae01f97968079d8db6e86
331.9 kB Preview Download

Additional details

References

  • 1. Akhter, Taslima, et al. "Chemical and Pharmacological Potential of Adiantum Philippense Linn and Further Molecular Simulation Study of Its Compounds Against COX-2: An Unexplored Medicinal Fern." Tropical Journal of Natural Product Research, vol. 7, no. 9, Oct. 2023, https://doi.org/10.26538/tjnpr/v7i9.1. 2. Bemidinezhad, Abolfazl, et al. "Evaluation of Acute, Subacute, and Subchronic Toxicity of a Hepatoprotective Herbal Formulation." Toxicology Reports, vol. 11, Nov. 2023, p. 452, https://doi.org/10.1016/j.toxrep.2023.11.002. 3. Dehdari, Sahar, and Homa Hajimehdipoor. "Medicinal Properties of Adiantum Capillus-Veneris Linn. in Traditional Medicine and Modern Phytotherapy: A Review Article." PubMed, vol. 47, no. 2, Feb. 2018, p. 188, https://pubmed.ncbi.nlm.nih.gov/29445628. 4. Mou, Linru, et al. "Wound Healing and Photodynamic Potential of Adiantum Capillus-Veneris L. (Pteridaceae): An Evaluation of the Cellular Effects and Molecular Insights." Frontiers in Pharmacology, vol. 16, Jan. 2026, p. 1729572, https://doi.org/10.3389/fphar.2025.1729572. 5. Pan, Cun-De, et al. "Phytochemical Constituents and Pharmacological Activities of Plants from the Genus Adiantum: A Review." Tropical Journal of Pharmaceutical Research, vol. 10, no. 5, Nov. 2011, https://doi.org/10.4314/tjpr.v10i5.18. 6. Qadir, Syamand Ahmed, et al. "Adiantum Capillus‐veneris: A Comprehensive Review of Its Medicinal Properties, Bioactive Compounds, and Advanced Extraction Techniques." Food Science & Nutrition, vol. 13, no. 10, Oct. 2025, https://doi.org/10.1002/fsn3.71118. 7. Rastogi, Subha, et al. "Ethnopharmacological Uses, Phytochemistry and Pharmacology of Genus Adiantum: A Comprehensive Review." Journal of Ethnopharmacology, vol. 215, Dec. 2017, p. 101, https://doi.org/10.1016/j.jep.2017.12.034. 8. Viral, D., et al. "Anticancer Evaluation of Adiantum Venustum Don." Journal of Young Pharmacists, vol. 3, no. 1, Jan. 2011, p. 48, https://doi.org/10.4103/0975-1483.76419.